The Online Cancer News and Information
New Zealand women will have access to the world’s first vaccine for cervical cancer from today. Gardasil has been registered by Medsafe as a vaccine for all girls and women aged nine to 26. The course of three injections costs 450 U.S. dollars and has not yet been approved for inclusion in the government-funded schedule [...]
{ 0 comments }
Hormone refractory prostate cancer is when the prostate cancer cells continue to grow after an initial period of success with hormonal therapy. Most prostate cancers are hormone dependent and require male sex hormones to grow, usually over time the prostate cancer cells develop the ability to grow in the absence of the male hormones. In [...]
{ 0 comments }
Eisai Co., Japan’s fourth-largest drugmaker, said it bought exclusive rights to four cancer-related treatments from Ligand Pharmaceuticals Inc. for $205 million in cash to help establish the company’s global oncology business. Eisai, best known for its Alzheimer’s treatment drug Aricept, does not have any cancer drugs on the market but has made cancer treatments one [...]
{ 0 comments }
The top five targeted cancers, according to the latest news are melanoma, breast, lung, prostate, and colorectal cancer. At present there are 600 clinical trials going on which involves 340 immunotherapy drugs in around 200 companies. All working for one mission, that is, the study to attempt the treatment for all cancers. There are around [...]
{ 0 comments }
Around 40 New Zealand breast cancer patients are hoped to be taking part in an international drug trial which aims to improve medication used to prevent recurrence of the disease. The trial will compare two new aromatatse inhibitors – treatments which effectively starve breast cancer cells of oestrogen, preventing the disease from recurring in post-treatment [...]
{ 0 comments }
LONDON (Reuters) – GlaxoSmithKline’s experimental vaccine against a virus that causes cervical cancer could cut the number of cases and deaths from the illness by up to 76 percent, the drug company said on Monday. The vaccine known as Cervarix prevents infection from two strains of the human papillomavirus (HPV) which account for about 70 [...]
{ 1 comment }
Herceptin, one of the first generation of targeted cancer therapies, is a monoclonal antibody that binds to a specific protein, known as HER-2, found in abundance on the surface of certain types of breast cancer cells. Taking a cue from the success of this agent, investigators at the University of Michigan have used a similar [...]
{ 0 comments }
LONDON (Reuters) – The world’s first cervical cancer vaccine may give wider protection against the killer disease than previously thought, researchers said on Sunday. New data presented at a medical conference in Prague showed Merck & Co Inc’s Gardasil had the potential to neutralise additional strains of the sexually transmitted human papillomavirus (HPV) that causes [...]
{ 0 comments }
oncerns that the newer rheumatoid arthritis drugs used to treat the sickest patients increase cancer risk aren’t supported, according to a new study. The findings should reassure patients who take Enbrel, Remicade, or Humira. All of these drugs are so-called biologics — meaning they are derived from living organisms. They are known as necrosis factor [...]
{ 0 comments }
The addition of further chemotherapy added to neoadjuvant chemotherapy in patients with esophageal cancer can improve survival. When diagnosed with esophageal cancer the patient is usually given chemotherapy to shrink the tumor before surgery, it also may be accompanied by radiation. This gives a better chance that the tumor will be smaller and can be [...]
{ 0 comments }
WEDNESDAY, Aug. 30 (HealthDay News) — The final word on whether the cox-2 painkiller Celebrex might be used to prevent colon cancer is a definite “no,” according to the long-awaited results of two major studies. Both of the three-year trials found that the drug reduced the occurrence of precancerous polyps called adenomas in people at [...]
{ 0 comments }
PHARMAC has announced it is to fund a taxane drug for use in early stage breast cancer. The decision to fund Paclitaxel from tomorrow is expected to see up to 550 women with early breast cancer treated with the medicine. Taxanes are a class of chemotherapeutic drug funded for a number of cancers including ovarian, [...]
{ 0 comments }
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||